Ramelteon is the first in a new class of sleep agents that selectively binds to the melatonin receptors in the suprachiasmatic nucleus (SCN). It is used for insomnia, particularly delayed sleep onset. Ramelteon has not been shown to produce dependence and has shown no potential for abuse. Ramelteon is a Melatonin Receptor Agonist. The mechanism of action of ramelteon is as a Melatonin Receptor Agonist. It is grouped under the following drug class(es): Hypnotics, Psychotropic agents and Sedatives. Its therapeutic use is listed as sleeping drugs. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Rozerem, ramelteonum and TAK-375. Its PubChem CID is 208902.
Ramelteon
| CAS No | 196597-26-9 |
|---|---|
| Molecular Formula | C16H21NO2 |
| Molecular Weight | 259.34 g/mol |
| Synonyms | N-[2-[(8S)-2,6,7,8-tetrahydro-1H-cyclopenta[e][1]benzofuran-8-yl]ethyl]propanamide |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Ramelteon is the first in a new class of sleep agents that selectively binds to the melatonin receptors in the suprachiasmatic nucleus (SCN). It is used for insomnia, particularly delayed sleep onset.
The listed CAS number is 196597-26-9.
The listed molecular formula is C16H21NO2.
The listed molecular weight is 259.34 g/mol.
N-[2-[(8S)-2,6,7,8-tetrahydro-1H-cyclopenta[e][1]benzofuran-8-yl]ethyl]propanamide.
The source lists Rozerem, ramelteonum and TAK-375.